Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal
New Delhi: Merck is in talks to buy cancer drug developer Revolution Medicines in a USD 28 billion to USD 32 billion deal, the Financial Times reported on Thursday, citing…